These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease. Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152 [No Abstract] [Full Text] [Related]
4. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease. Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151 [No Abstract] [Full Text] [Related]
5. [Erythropoietin]. Pavlović-Kentera V Srp Arh Celok Lek; 1989; 117(9-10):643-8. PubMed ID: 18709763 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin. Chandra M; McVicar M; Clemons GK Adv Pediatr; 1988; 35():361-89. PubMed ID: 3055863 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin: from mountain top to bedside. Erslev AJ; Caro J Adv Exp Med Biol; 1989; 271():1-7. PubMed ID: 2486278 [No Abstract] [Full Text] [Related]
9. [Anemia in acute renal failure and chronic renal failure]. Koide K; Sano M; Takeda F; Morio K; Momose T Nihon Rinsho; 1991 Mar; 49(3):685-9. PubMed ID: 2041197 [No Abstract] [Full Text] [Related]
11. DOQI Guidelines/fifth in a series. A focus on iron management for better HcTs. Nephrol News Issues; 1997 Sep; 11(9):39, 53. PubMed ID: 9348872 [No Abstract] [Full Text] [Related]
12. Erythropoietin: from molecular biology to clinical use. Lacombe C Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370 [No Abstract] [Full Text] [Related]
13. Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Erslev AJ; Besarab A Kidney Int; 1997 Mar; 51(3):622-30. PubMed ID: 9067892 [No Abstract] [Full Text] [Related]
14. [Anemia in chronic renal insufficiency]. Blumberg A Schweiz Med Wochenschr; 1972 Jul; 102(30):1044-9. PubMed ID: 4572956 [No Abstract] [Full Text] [Related]
15. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia]. Nikolaev AIu; Klepikov PV; Lashutin SV Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349 [No Abstract] [Full Text] [Related]
16. [Erythropoietin: its biological properties and clinical use]. Ermolenko VM; Nikolaev AIu Ter Arkh; 1990; 62(11):141-5. PubMed ID: 2094979 [No Abstract] [Full Text] [Related]
17. [Treatment of anemia caused by chronic kidney failure in adults]. Nephrol Ther; 2005 Aug; 1 Suppl 1():S1-48. PubMed ID: 16895707 [No Abstract] [Full Text] [Related]
18. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
19. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. Eschbach JW; Kelly MR; Haley NR; Abels RI; Adamson JW N Engl J Med; 1989 Jul; 321(3):158-63. PubMed ID: 2747747 [TBL] [Abstract][Full Text] [Related]
20. Interrelationship between erythropoietin and erythropoiesis: insights from renal transplantation. Lee DB Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):54-6. PubMed ID: 1928080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]